Sinensetin ameliorates high glucose‐induced diabetic nephropathy via enhancing autophagy in vitro and in vivo
Journal of Biochemical and Molecular Toxicology · 2023
DOI: 10.1002/jbt.23445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2023. Verfasst von Zili Kong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Affiliated Hospital of Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Autophagy, Diabetic Nephropathies, Glucose, Flavonoids. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Qingdao science and technology demonstration and guidance project.
Abstract (Originalsprache)
Diabetic nephropathy (DN) affects around 40% of people with diabetes, the final outcome of which is end‐stage renal disease. The deficiency of autophagy and excessive oxidative stress have been found to participate in the pathogenesis of DN. Sinensetin (SIN) has been proven to have strong antioxidant capability. However, the effect of SIN on DN has not been studied. We examined the effect of SIN on cell viability and autophagy in the podocyte cell line, MPC5 cells, treated with high glucose (HG). For in vivo studies, DN mice models were established by intraperitoneal injected with streptozotocin (40 mg/kg) for 5 consecutive days and fed with a 60% high‐fat diet, and SIN was given (10, 20, and 40 mg/kg) for 8 weeks via intraperitoneal injection. The results showed that SIN could protect MPC5 cells against HG‐induced damage and significantly improve the renal function of DN mice. Moreover, SIN remarkably restored the autophagy activity of MPC5 cells which was inhibited under HG conditions. Consistent with this, SIN efficiently improved autophagy in the kidney tissue of DN mice. In brief, our findings demonstrated the protective effect of SIN on DN via restoring the autophagic function, which might provide a basis for drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Affiliated Hospital of Qingdao University, Qingdao, China.
- Department of Endocrinology and Metabolism, Qingdao Key Laboratory of Thyroid Diseases, Medical Research Center, Affiliated Hospital of Qingdao University, Qingdao, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Qingdao science and technology demonstration and guidance project
Zitieren
APA
Kong, Z., Lv, W., Wang, Y., Huang, Y., Che, K., Nan, H., Xin, Y., Wang, J., Chen, J., Wang, Y., & Chi, J. (2023). Sinensetin ameliorates high glucose‐induced diabetic nephropathy via enhancing autophagy in vitro and in vivo. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23445
Vancouver
Kong Z, Lv W, Wang Y, Huang Y, Che K, Nan H, et al. Sinensetin ameliorates high glucose‐induced diabetic nephropathy via enhancing autophagy in vitro and in vivo. Journal of Biochemical and Molecular Toxicology. 2023. doi:10.1002/jbt.23445
BibTeX
@article{Kong2023,
author = {Kong, Zili and Lv, Wenshan and Wang, Yunyang and Huang, Yajing and Che, Kui and Nan, Huiqi and Xin, Yu and Wang, Jiaxuan and Chen, Jintao and Wang, Yangang and Chi, Jingwei},
title = {Sinensetin ameliorates high glucose‐induced diabetic nephropathy via enhancing autophagy in vitro and in vivo},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2023},
doi = {10.1002/jbt.23445}
}
EUVIMED